Eversept Partners, LP Puma Biotechnology, Inc. Transaction History

Eversept Partners, LP

  • $904 Million
  • Q1 2025

A detailed history of Eversept Partners, LP transactions in Puma Biotechnology, Inc. stock. As of the latest transaction made, Eversept Partners, LP holds 275,788 shares of PBYI stock, worth $970,773. This represents 0.09% of its overall portfolio holdings.

Number of Shares
275,788
Previous 996,102 72.31%
Holding current value
$970,773
Previous $3.04 Million 73.14%
% of portfolio
0.09%
Previous 0.31%

Shares

37 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025
SELL
$2.76 - $3.88 $1.99 Million - $2.79 Million
-720,314 Reduced 72.31%
275,788 $816,000
Q4 2024

Feb 14, 2025
SELL
$2.42 - $3.39 $719,115 - $1.01 Million
-297,155 Reduced 22.98%
996,102 $3.04 Million
Q3 2024

Nov 14, 2024
SELL
$2.25 - $4.03 $79,193 - $141,843
-35,197 Reduced 2.65%
1,293,257 $3.3 Million
Q2 2024

Aug 14, 2024
SELL
$2.92 - $5.83 $286,285 - $571,590
-98,043 Reduced 6.87%
1,328,454 $4.33 Million
Q1 2024

May 15, 2024
SELL
$4.29 - $7.4 $1.15 Million - $1.99 Million
-268,524 Reduced 15.84%
1,426,497 $7.56 Million
Q4 2023

Feb 14, 2024
BUY
$2.23 - $4.49 $30,934 - $62,285
13,872 Added 0.83%
1,695,021 $7.34 Million
Q3 2023

Nov 14, 2023
BUY
$2.63 - $4.09 $60,369 - $93,881
22,954 Added 1.38%
1,681,149 $4.42 Million
Q2 2023

Nov 08, 2023
SELL
$2.6 - $3.58 $727,721 - $1 Million
-279,893 Reduced 14.44%
1,658,195 $5.85 Million
Q2 2023

Aug 14, 2023
SELL
$2.6 - $3.58 $727,721 - $1 Million
-279,893 Reduced 14.44%
1,658,195 $5.85 Million
Q1 2023

Nov 08, 2023
BUY
$2.21 - $4.82 $951,239 - $2.07 Million
430,425 Added 28.55%
1,938,088 $5.99 Million
Q1 2023

May 15, 2023
BUY
$2.21 - $4.82 $951,239 - $2.07 Million
430,425 Added 28.55%
1,938,088 $5.99 Million
Q4 2022

Nov 08, 2023
BUY
$2.12 - $5.08 $4,150 - $9,946
1,958 Added 0.13%
1,507,663 $6.38 Million
Q4 2022

Feb 14, 2023
BUY
$2.12 - $5.08 $4,150 - $9,946
1,958 Added 0.13%
1,507,663 $6.38 Million
Q3 2022

Nov 08, 2023
BUY
$2.27 - $3.84 $160,325 - $271,211
70,628 Added 4.92%
1,505,705 $3.54 Million
Q3 2022

Nov 14, 2022
BUY
$2.27 - $3.84 $160,325 - $271,211
70,628 Added 4.92%
1,505,705 $3.57 Million
Q2 2022

Nov 08, 2023
BUY
$1.64 - $3.3 $17,100 - $34,409
10,427 Added 0.73%
1,435,077 $4.09 Million
Q2 2022

Aug 15, 2022
BUY
$1.64 - $3.3 $17,100 - $34,409
10,427 Added 0.73%
1,435,077 $4.09 Million
Q1 2022

Nov 08, 2023
SELL
$2.13 - $3.24 $497,450 - $756,685
-233,545 Reduced 14.08%
1,424,650 $4.1 Million
Q1 2022

May 16, 2022
BUY
$2.13 - $3.24 $653,381 - $993,876
306,752 Added 27.44%
1,424,650 $4.1 Million
Q4 2021

Nov 08, 2023
BUY
$2.85 - $6.58 $2.05 Million - $4.74 Million
719,958 Added 180.92%
1,117,898 $3.4 Million
Q4 2021

Feb 14, 2022
BUY
$2.85 - $6.58 $2.05 Million - $4.74 Million
719,958 Added 180.92%
1,117,898 $3.4 Million
Q3 2021

Nov 08, 2023
SELL
$6.63 - $9.39 $8.36 Million - $11.8 Million
-1,260,255 Reduced 76.0%
397,940 $2.79 Million
Q3 2021

Nov 15, 2021
BUY
$6.63 - $9.39 $2.64 Million - $3.74 Million
397,940 New
397,940 $2.79 Million
Q2 2020

Aug 13, 2020
SELL
$7.01 - $13.24 $408,339 - $771,243
-58,251 Closed
0 $0
Q1 2020

Nov 08, 2023
BUY
$6.28 - $14.57 $100,166 - $232,391
15,950 Added 37.71%
58,251 $491,000
Q1 2020

May 13, 2020
BUY
$6.28 - $14.57 $365,816 - $848,717
58,251 New
58,251 $492,000
Q1 2019

May 14, 2019
SELL
$20.77 - $42.37 $878,591 - $1.79 Million
-42,301 Closed
0 $0
Q4 2018

Nov 08, 2023
BUY
$20.07 - $46.7 $414,044 - $963,421
20,630 Added 95.2%
42,301 $860,000
Q4 2018

Feb 13, 2019
BUY
$20.07 - $46.7 $414,044 - $963,421
20,630 Added 95.2%
42,301 $861,000
Q3 2018

Nov 08, 2023
SELL
$41.2 - $59.85 $92,823 - $134,842
-2,253 Reduced 9.42%
21,671 $993,000
Q3 2018

Nov 14, 2018
SELL
$41.2 - $59.85 $92,823 - $134,842
-2,253 Reduced 9.42%
21,671 $994,000
Q2 2018

Nov 08, 2023
BUY
$48.3 - $68.25 $48,300 - $68,250
1,000 Added 4.36%
23,924 $1.42 Million
Q2 2018

Aug 14, 2018
BUY
$48.3 - $68.25 $48,300 - $68,250
1,000 Added 4.36%
23,924 $1.42 Million
Q1 2018

Nov 08, 2023
SELL
$59.7 - $99.25 $97.6 Million - $162 Million
-1,635,271 Reduced 98.62%
22,924 $1.56 Billion
Q1 2018

May 14, 2018
SELL
$59.7 - $99.25 $1.89 Million - $3.15 Million
-31,725 Reduced 58.05%
22,924 $1.56 Million
Q4 2017

Nov 08, 2023
SELL
$93.85 - $132.45 $150 Million - $212 Million
-1,603,546 Reduced 96.7%
54,649 $5.4 Billion
Q4 2017

Feb 12, 2018
BUY
$93.85 - $132.45 $5.13 Million - $7.24 Million
54,649
54,649 $5.4 Million

Others Institutions Holding PBYI

# of Institutions
116
Shares Held
30.9M
Call Options Held
32.7K
Put Options Held
200
View Full List

About PUMA BIOTECHNOLOGY, INC.

PBYI Quotes by TradingView
  • Ticker PBYI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,556,000
  • Market Cap $160M
  • Description
  • Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...
More about PBYI
Track This Portfolio

Track Eversept Partners, LP Portfolio

Follow Eversept Partners, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eversept Partners, LP, based on Form 13F filings with the SEC.

News

Stay updated on Eversept Partners, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email